Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D4T8JV
|
|||
Drug Name |
Zelenoleucel
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 2 | [1] | |
Company |
Marker Therapeutics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04511130) A Phase 2 Study of Donor-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-401) Administered to Patients With Acute Myeloid Leukemia (AML) Following Hematopoietic Stem Cell Transplantation. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.